Open AccessCompound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential
Author(s) -
Thomas Unger,
Björn Dahlöf
Publication year - 2009
Publication title -
jraas. journal of the renin-angiotensin-aldosterone system/journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320309347792
Subject(s) - orally active , agonist , pharmacology , receptor , partial agonist , chemistry , medicine , oral administration